Pharmatech Selected as a Top 50 2015 Colorado Company to Watch
Jun 19, 2015, 09:15 ET
DENVER, June 19, 2015 /PRNewswire/ -- With a company-applaud, Pharmatech, Inc. today announced it was selected as a top 50 2015 Colorado Company to Watch. Of 1,200 privately owned companies that were nominated, only 50 received this high-designated distinction.
"We attribute Pharmatech growth and innovation in cancer clinical trial management and our commitment to our pharmaceutical clients, physicians and cancer patients," said Pharmatech CEO Rob Bohacs.
Colorado Companies to Watch is an awards program honoring companies headquartered in the state of Colorado. These companies demonstrate high performance in the marketplace or exhibit innovative products or processes. The awards program is designed to seek businesses from a wide range of industries throughout the state, not just the major metropolitan areas. The companies selected each year make an astounding impact on Colorado's economy by collectively providing thousands of jobs and contributing millions of dollars in revenue. In short, they tell a compelling story about the state's diverse economic landscape.
"We are honored to be included in this short list of who's who among private Colorado companies," Bohacs said. "We look forward to continued growth not only for Pharmatech but also for the Colorado economy."
About Pharmatech, Inc.
Pharmatech, Inc. is an oncology Contract Research Organization (CRO) that manages clinical trial processes. Through an organized network of cancer clinics, the company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and on promoting the inclusion of clinical trials in the spectrum of patient treatment options.
For more information about Pharmatech, please visit: http://www.pharmatech.com or contact us at [email protected]
SOURCE Pharmatech, Inc.
Share this article